Jesse Singh; President, Chief Executive Officer, Director; Azek Company Inc Ryan Lada; Senior Vice President, Chief Financial Officer & Treasurer; Azek Company Inc Ladies and gentlemen, I'd like to ...

ADC Therapeutics SA (NYSE: ADCT) Q1 2025 Earnings Call Transcript May 14, 2025 ADC Therapeutics SA beats earnings ...

About PYRUKYND® (mitapivat) U.S. INDICATION PYRUKYND is a pyruvate kinase activator indicated for the treatment of hemolytic anemia in adults with pyruvate kinase (PK) deficiency.

The company's move to diversify its product line into into tanks and chambers for water management spured its growth.

The sixth annual virtual Positivity Summit continued with three more presentations designed to help collision business owners ...

The clinical, cardiovascular and neuroendocrine profile of ampreloxetine showed target engagement of residual peripheral autonomic neurons and a sustained standing blood pressure effect, which is ...

Q1 2025 Earnings Call Transcript May 15, 2025 Operator: Hello, and welcome to VEON’s First Quarter 2025 Results Presentation.

During its presentation last year, Netflix announced plans to build its own bespoke ad tech platform to solve advertiser ...

At this time, I would like to welcome everyone to Virgin Galactic's First Quarter 2025 Earnings Conference Call. All lines have been placed on mute to prevent any background noise. After the speakers' ...

Luminar Technologies, Inc. (NASDAQ: LAZR) Q1 2025 Earnings Call Transcript May 14, 2025 Luminar Technologies, Inc. beats ...

The Marketing Authorization Application (MAA) for Day One Biopharmaceuticals and Ipsen’s tovorafenib was accepted for review ...

As past and current events continue to remind us, disruptive change is a reality. Protiviti's Jim DeLoach examines new global ...